The main goal of this study is to assess whether a mobile phone app called MiDiálisis is practical, easy to use, and well-accepted. The app was developed by the Technical University of Madrid (UPM) and is designed to bring together the clinical data of people with chronic kidney disease who are on peritoneal dialysis. This way, both patients and doctors can access the information at any time.
This is a free smartphone app that collects information in three ways: 1. The patient will enter their blood pressure and ultrafiltration values. 2. They will receive a digital scale that sends their weight and body composition to the MiDiálisis app via Bluetooth. 3. They will receive a smartband that sends information about their heart rate, sleep pattern, and physical activity to the MiDiálisis app via Bluetooth.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
55
During Phase 2, patients will use the smart band continuously throughout the day.
During Phase 2, patients will weigh themselves daily using the scale.
Patients will enter daily blood pressure data and information related to their peritoneal dialysis therapy.
Hospital 12 de Octubre
Madrid, Madrid, Spain
RECRUITINGFeasibility and adherence
To assess the feasibility and adherence to the use of MiDiálisis among patients undergoing peritoneal dialysis (PD), defined as the number of times per week that the patient or caregiver accesses the MiDiálisis app.
Time frame: The investigators analized the number of times that patient or caregiver access the MiDialisis app during 8 weeks that the patient would be installed the App in his mobile.
Perceived quality
To assess patient and caregiver satisfaction (perceived quality, visit 4) with the use of MiDiálisis, measured using the Mobile App Rating Scale (MARS), (23 items, max. 115 points, higher scores mean a better outcome).
Time frame: After 8 weeks of using mobile App (week +16 from recruitment), the patient or caregiver will filled Mobile App Rating Scale (MARS) to analized satisfaction grade.
Usability
To assess healthcare professionals' satisfaction with the use of the MiDiálisis dashboard. the healthcare professional will filled the System Usability Scale (SUS) (10 items, max 50 points, higher scores mean a better outcome).
Time frame: After 8 weeks using MiDialisis dashboard (week +16 from recruitment, visit 4).
In-person Clinical care
Changes in in-person clinical care, measured as the number of face-to-face visits across Phase 1, Phase 2, and Phase 3.
Time frame: At the end of the study (week +24 from recruitment, visit 5).
telephone-based clinical care
Changes in telephone-based clinical care, measured as differences in the number of telephone calls across Phase 1, Phase 2, and Phase 3.
Time frame: At the end of the study (week +24 from recruitment, visit 5).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Patients will download and begin using the application.
Patients will connect the digital scale to the application via Bluetooth.
Patients will connect the smartband to the application via Bluetooth.
unscheduled visits
Changes in the number of unscheduled visits.Measured as the number of unscheduled visits between Phase 1, Phase 2, and Phase 3.
Time frame: At the end of the study (week +24 from recruitment, visit 5).
overall clinical care
Changes in overall clinical care. Measured as the number of interactions in the MiDiálisis chat vs. another objetives.
Time frame: At the end of the study (week +24 from recruitment, visit 5).
Kidney Disease Quality of Life-36
Changes in patient-reported health outcomes (PROMs) with MiDiálisis between Phase 1 and Phase 2. Measured using the Kidney Disease Quality of Life-36 (KDQOL-36) scale (36 items, max 100 points, higher scores mean a better outcome.).
Time frame: At the end of the study (week +24 from recruitment, visit 5).
Kidney Disease and Quality of Life™ Short Form
Changes in patient-reported health experience (PREMS) with the use of MiDiálisis between Phase 1 and Phase 2. Measured with the Kidney Disease and Quality of Life™ Short Form (KDQOLSF) (24 items, quantitative, higher scores mean a better outcome).
Time frame: At the end of the study (week +24 from recruitment, visit 5).
Pittsburgh Sleep Quality Index
Assess subjective changes in sleep quality between Phase 1 and Phase 2. Measured using the Pittsburgh Sleep Quality Index (PSQI) (19 items, max 21 points, higher scores mean a worse outcome).
Time frame: At the end of the study (week +24 from recruitment, visit 5).
Physical Activity Questionnaire
Assess changes in physical activity between Phase 1 and Phase 2. Measured using the International Physical Activity Questionnaire (IPAQ) (7 items, quantitative, higher scores indicate higher levels of physical activity).
Time frame: At the end of the study (week +24 from recruitment, visit 5).